Recruiting

BIA Test

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07855627

Conditions

Lymphedema

Inflammatory Breast Cancer (IBC)

Preoperative

Bioimpedance Measurement

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Neoadjuvant therapy

Study Details

Brief summary:

To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.

Conditions

Lymphedema

Inflammatory Breast Cancer (IBC)

Preoperative

Bioimpedance Measurement

Study ID

NCT07855627

Start date

Sep 16, 2026

Status verified date

Sep, 2026

Completion date

Dec 31, 2029

Anticipated

Primary completion date

Dec 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Eligibility Criteria All women≄18 years old with newly diagnosed inflammatory breast cancer without prior breast/axillary surgery who are eligible for standard of care (NST, MRM, and radiation therapy).

Exclusion Criteria Prior breast/axillary surgery. Participants with pacemakers or other implanted electronic medical devices. Participants with implanted metallic material. All vulnerable populations, including children, pregnant women, and cognitively impaired adult

Study Design

Enrollment

150 participants

Anticipated

Interventions and Outcome Measures

Interventions

Neoadjuvant therapy

all patients will start/continue neoadjuvant systemic therapy

Primary outcome measure

  • Lymphedema Life Impact Scale (LLIS) questionnaire [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts and Locations

Central contacts

Anthony Lucci, MD

713-563-1871ALucci@mdanderson.org

Locations

UT MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Anthony Lucci, MD

713-563-1871ALucci@mdanderson.org

Principal Investigator:

Anthony Lucci, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Oct 2, 2026

Last verified

Sep, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-03. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-10-02. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.